Hand of the Market
Screener
Sectors
Compare
Insider buys
Funds
 Screener

TGTX TG THERAPEUTICS, INC.

Compare with sector and industry Screen the industry

Health Care · Pharmaceuticals & Biotechnology · data as of 2026-10-22 · latest quarter 2026-06-30, filed 2026-08-05

Market cap
$8.14B
P/E (trailing)
18.4×
P/E vs. sector
0.7×
FCF yield
0.2%
Avg daily $ volume
$108.34M
Days to next report
13
Quality checklist

5 of 6 checks passed · quarter ending 2026-06-30

  • ROIC at least 10%15.7%
  • Operating margin up over 3 years+824.4 pp
  • Free cash flow at least 80% of net income3.9%
  • Share count up at most 5% in 3 years1.4%
  • Net debt at most 3× EBITDA1.9×
  • Revenue grew over 3 years221.5%
Insider buying, last 90 days

No discretionary insider buying in the last 90 days.

Tracked funds, latest reports
Active managers
+$180.84M +2.2 pp of the company
3 buying · 0 selling · 3 holding
Mutual funds & ETFs
+$463.22K +0.0 pp of the company
1 buying · 0 selling · 2 holding

Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.

Size & liquidity
TGTXSector12 quartersMarket cap$8.14B$9.67BEnterprise value$8.4B$10.41BAvg daily $ volume$108.34M$132.68MDaily turnover1.3%1.3%
Growth
TGTXSector12 quartersRevenue CAGR 3y221.5%9.5%423.7% → 221.5%Revenue CAGR 5y219.2%8.9%Revenue growth YoY70.3%8.7%176298.9% → 70.3%Revenue acceleration+0.7 pp+0.0 pp+173692.9 pp → +0.7 ppFCF growth YoY—5.9%FCF conversion3.9%130.8%-173.5% → 3.9%Forward growth (HoM est.)50.0%9.8%
Valuation
TGTXSector12 quartersP/E (trailing)18.4×27.6×P/E (forward, HoM est.)12.3×25.2×P/E vs. sector0.7×1.0×PEG (HoM est.)0.253.12EV/EBITDA61.6×17.5×EV/Sales10.5×3.3×FCF yield0.2%3.6%Dividend yield0.0%0.0%Shareholder yield0.0%1.2%
Quality
TGTXSector12 quartersQuality checks passed53ROIC15.7%9.2%-31.1% → 15.7%Gross profitability40.2%32.6%55.4% → 40.2%Gross margin82.4%60.1%96.7% → 82.4%Gross margin Δ 3y−6.1 pp−0.1 ppOperating margin17.1%10.6%-23.4% → 17.1%Operating margin Δ 3y+824.4 pp+0.9 pp+14080.7 pp → +824.4 ppDebt/equity1.2×0.7×0.6× → 1.2×Net debt/EBITDA1.9×2.0×0.4× → 1.9×Interest coverage3.6×4.9×-3.4× → 3.6×Share count Δ 3y1.4%-0.3%17.5% → 1.4%Stock compensation / revenue10.2%1.8%34.3% → 10.2%Accruals ratio36.2%-4.3%-3.4% → 36.2%
Earnings & estimates
TGTXSector12 quartersDays to next report1313
Ownership & positioning
TGTXSector12 quartersInsider buys (90d)00Insiders buying (90d)00Insider net value (90d)-$274.8K$0Institutional ownership72.5%99.6%Institutional Δ QoQ+3.1 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying+2.2 pp+0.1 ppActive funds net buying+0.0 pp+0.0 ppDays to cover15.034.29Short % of shares out20.0%6.0%Short interest Δ+0.3 pp+0.1 pp

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Terms of use

Source: SEC EDGAR: Forms 4 (insider trades), 10-Q and 10-K (financials). Insider trades as filed (amendments applied); financial metrics computed by Hand of the Market from the companies' quarterly and annual reports. Each trade links to its filing.

Not investment advice. These signals are starting points for research, not recommendations. Data may contain errors or lag the filings.